| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Division of Human Cancer Genetics, Ohio State University, Columbus, Ohio 43210 [J. H., R. B. C., C. K. J., M. W. S., S. K. R., J. E. M., X. G., F. A. W., P. P.]; Department of Medical Genetics, University of Helsinki, FIN-00014 Helsinki, Finland [S. A. K.]; Karolinska Institute, S-17176 Stockholm, Sweden [T. L., A. L.]; Department of Surgery, Jyväskylä Central Hospital, FIN-40620 Jyväskylä, Finland [J-P. M.]; Second Department of Surgery, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland [H. J. J.]; Department of Oncology, University Hospital, S-90185 Umeå, Sweden [H. G.]; and Rigshospitalet and Danish Hereditary Nonpolyposis Colon Cancer Registry, DK-2100 Copenhagen, Denmark [M. L. B.]
A set of 90 nonpolypotic colon cancer families in which germ-line mutations of MSH2 and MLH1 had been excluded were screened for mutations in two additional DNA mismatch repair genes, MSH6 and MSH3. Kindreds fulfilling and not fulfilling the Amsterdam I criteria, showing early and late onset colorectal (and other) cancers, and having microsatellite stable and unstable tumors were included. Two partly parallel approaches were used: genetic linkage analysis (19 large families) and the protein truncation test (85, mostly smaller, families). Whereas MSH3 was not involved in any family, a large Amsterdam-positive, late-onset family showed a novel germ-line mutation in MSH6 (deletion of CT at nucleotide 3052 in exon 4). The mutation was identified through genetic linkage (multipoint lod score 2.4) and subsequent sequencing of MSH6. Furthermore, the entire MSH6 gene was sequenced exon by exon in families with frameshift mutations in the (C)8 tract in tumors, previously suggested as a predictor of MSH6 germ-line mutations; no mutations were found. We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.
This article has been cited by other articles:
![]() |
K. Lagerstedt Robinson, T. Liu, J. Vandrovcova, B. Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, P. Peltomaki, et al. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics J Natl Cancer Inst, February 21, 2007; 99(4): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Woods, A. J. Hyde, F. K. Curtis, S. Stuckless, J. S. Green, A. F. Pollett, J. D. Robb, R. C. Green, M. E. Croitoru, A. Careen, et al. High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes Clin. Cancer Res., October 1, 2005; 11(19): 6853 - 6861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ollikainen, W. M. Abdel-Rahman, A.-L. Moisio, A. Lindroos, R. Kariola, I. Jarvela, M. Poyhonen, R. Butzow, and P. Peltomaki Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome? J. Clin. Oncol., July 20, 2005; 23(21): 4609 - 4616. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vahteristo, S Ojala, A Tamminen, J Tommiska, H Sammalkorpi, S Kiuru-Kuhlefelt, H Eerola, L A Aaltonen, K Aittomaki, and H Nevanlinna No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer J. Med. Genet., April 1, 2005; 42(4): e22 - e22. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Di Fiore, F Charbonnier, C Martin, S Frerot, S Olschwang, Q Wang, C Boisson, M-P Buisine, M Nilbert, A Lindblom, et al. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC J. Med. Genet., January 1, 2004; 41(1): 18 - 20. [Full Text] [PDF] |
||||
![]() |
E. Renkonen, Y. Zhang, H. Lohi, R. Salovaara, W. M. Abdel-Rahman, M. Nilbert, K. Aittomaki, H. J. Jarvinen, J.-P. Mecklin, A. Lindblom, et al. Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3629 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Liljegren, A Lindblom, S Rotstein, B Nilsson, C Rubio, and E Jaramillo Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps Gut, August 1, 2003; 52(8): 1140 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Goodfellow, B. M. Buttin, T. J. Herzog, J. S. Rader, R. K. Gibb, E. Swisher, K. Look, K. C. Walls, M.-Y. Fan, and D. G. Mutch Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers PNAS, May 13, 2003; 100(10): 5908 - 5913. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-X. Liu, X.-L. Zhou, T. Liu, B. Werelius, G. Lindmark, N. Dahl, and A. Lindblom The Role of hMLH3 in Familial Colorectal Cancer Cancer Res., April 15, 2003; 63(8): 1894 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Charbonnier, S. Olschwang, Q. Wang, C. Boisson, C. Martin, M.-P. Buisine, A. Puisieux, and T. Frebourg MSH2 in Contrast to MLH1 and MSH6 Is Frequently Inactivated by Exonic and Promoter Rearrangements in Hereditary Nonpolyposis Colorectal Cancer Cancer Res., February 1, 2002; 62(3): 848 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, H. Yan, S. Kuismanen, A. Percesepe, M.-L. Bisgaard, M. Pedroni, P. Benatti, K. W. Kinzler, B. Vogelstein, M. Ponz de Leon, et al. The Role of hPMS1 and hPMS2 in Predisposing to Colorectal Cancer Cancer Res., November 1, 2001; 61(21): 7798 - 7802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |